General Surgery Device - Market Insights, Competitive Landscape, and Market Forecast - 2030

General Surgery Device Market By Type (Robotics & Computer Assisted Surgery Device, Open Surgery Instruments, Energy Based And Powered Instruments, And Others), Product (Handheld Devices, Trocars And Access Devices, Endoscopic Devices, Electro Surgical Devices, Wound Closure Devices, General Surgical Kits, And Others), Consumables (Disposable Surgical Instruments And Surgical Drapes & Covers), Application (Urology, Orthopedic, Cardiology, Neurology, And Others), End-Users (Hospitals, Clinics, Ambulatory Surgical Centers, And Others) And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of chronic diseases, increasing integration of artificial intellegence in surgical devices, and increasing number of regulatory approvals for surgical devices across the globe.

The global general surgery device market is estimated to grow at a CAGR of 5.89% during the forecast period from 2024 to 2030. The demand for general surgery devices is primarily being boosted by the growing prevalence of chronic disease such as cardiovascular diseases, oncological disorders, and others. Several chronic diseases may require surgical intervention for the management or treatment thereby boosting the market of general surgery devices. Furthermore, the general surgery device market is anticipated to grow on account of a large number of technological advancements such as the integration of AI assistance in surgery-related devices and an increase in the number of product approvals across the globe. These are the major drivers that are responsible for contributing to the positive growth of the general surgery device market during the forecast period from 2024 to 2030.

General Surgery Device Market Dynamics

According to the latest data provided by the GLOBOCAN (2024), in 2022 globally the total number of new cases of colorectal cancer, gallbladder cancer, prostate cancer, kidney cancer, brain, and central nervous system cancers was estimated at 4.27 million, with projections suggesting that cancer cases will increase to 5.24 million by the year 2030. As the number of cancer cases increases, there is a growing need for diagnostic procedures such as biopsies, imaging-guided biopsies, and lymph node sampling to confirm the diagnosis and determine the stage of the disease. This requires the use of specialized surgical devices and instruments for tissue sampling and staging procedures, thereby boosting the market for general surgery devices.

According to the data provided by the World Health Organization (WHO) (2024), in 2022 globally out of 8 people, 1 person was living with obesity. Furthermore, as per the same source in 2022, approximately 2.5 billion people were overweight and out of these 890 million people were living with obesity worldwide. As the prevalence of obesity and related comorbidities continues to rise globally, there is a growing demand for bariatric surgery as an effective treatment option for severe obesity. This increased demand for bariatric procedures directly translates to a higher demand for surgical devices used in these surgeries.

Furthermore, the global market for general surgery devices is experiencing growth propelled by recent product launches worldwide. For instance, in 2022, CONMED Corporation marked the launch of Edge™ Laparoscopic Trocars, a new line of trocars boasting advanced blade technology engineered to optimize access efficiency and safety in the realm of minimally invasive surgeries. Thus, the increasing product launches are also playing a pivotal role in driving the overall market of general surgery devices.

However, the susceptibility to injuries and infection, encompassing potential complications like bleeding and tissue trauma, and stringent regulatory approvals associated with the surgical devices may result in slight obstacle to the growth of general surgery device market.

General Surgery Device Market Segment Analysis:

General Surgery Device Market by Type (Robotics & Computer Assisted Surgery Devices, Open Surgery Instruments, Energy Based and Powered Instruments, and Others), Product (Handheld Devices, Trocars and Access Devices, Endoscopic Devices, Electro Surgical Devices, Wound Closure Devices, General Surgical Kits, and Others), Consumables (Disposable Surgical Instruments and Surgical Drapes & Covers), Application (Urology, Orthopedic, Cardiology, Neurology, and Others), End-Users (Hospitals, Clinics, Ambulatory Surgical Centers, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the type segment of the general surgery device market, the robotic and computer-assisted surgery devices category is estimated to a mass a significant revenue share in the general surgery device market in 2023. The robotic and computer-assisted general surgery device enable minimally invasive surgery (MIS), which involves smaller incisions compared to traditional open surgery. These devices often incorporate high-definition cameras and advanced imaging technology that provide surgeons with superior visualization of the surgical site. Furthermore, the studies have shown that robotic surgery can result in improved patient outcomes, including reduced rates of complications, shorter recovery times, and better long-term functional outcomes.

Furthermore, the increasing regulatory approval encourages surgeons to adopt robotic-assisted surgery by validating the technology's effectiveness and reliability, leading to increased utilization of robotic devices in clinical practice. For instance, in February 2024 Virtual Incision has obtained FDA authorization for the MIRA Surgical System, making it the first miniaturized robotic-assisted surgery device approved for use in colectomy procedures. Additionally, in October 2021 Medtronic received the approval of CE Mark for its Hugo™ robotic-assisted surgery (RAS) system for urologic and gynaecologic procedures.

Therefore, according to the above mentioned factors and increasing recent approvals of robotic and computer-assisted surgery devices will register significant growth of the category, thereby driving the growth of the overall general surgery market during the forecast period.

North America Is Expected To Dominate The Overall General Surgery Device Market:

North America is expected to account for the highest proportion of the general surgery device market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from chronic disease such as cancer. Additionally, presence of advanced healthcare infrastructure and increasing product approvals and product launches with advanced technology is anticipated to boost the market of general surgical devices in North America.

One of the key supporting factors for the growth of the general surgery device market in the United States is the increasing incidence of chronic disorders. According to data from GLOBOCAN (2024), in 2022, North America witnessed collective estimated total number of 553,000 new cases of colorectal cancer, gallbladder cancer, prostate cancer, kidney cancer, brain, and central nervous system cancers. By 2030, this number is projected to increase to 632,000 cases. As the incidence of cancer rises, there is an increasing need for specialized surgical devices and instruments for tissue sampling and staging procedures. This growing demand for surgical devices is driven by the necessity to effectively manage and treat the rising number of cancer cases, thereby contributing to the expansion of the surgical devices market.

Additionally, according to the American Society for Metabolic and Bariatric Surgery 2021 data, a total of 256,000 bariatric surgeries were performed in the US in the year 2019. Therefore, the rising number of people suffering from obesity and opting for bariatric surgery will further raise the demand for general surgical devices thereby boosting the market in the region.

Furthermore, the increasing number of product launches in the region is also boosting the overall market of general surgical devices. For instance, in May 2021 US Medical Innovation introduced the new Canady Surgical System (CSS), the first robotic delivery system used for cancer surgery. This groundbreaking system serves as a standalone solution for robotic-assisted surgery across a spectrum of surgical procedures, including open, laparoscopic/mini-invasive, endoscopic, thoracoscopic, and trans-oral surgeries.

Additionally, in June 2023 US Medical Innovation obtained FDA approval for the Canady Flex RoboWrist, a cutting-edge robotic surgery device. This innovative instrument is handheld device, featuring a range of end effectors such as a hook, scissors, needle driver, dissector, and connector for seamless integration with the USMI XL-1000 electrosurgical generator. Thus, the recent developments in surgical devices and increase in the number of product approvals will eventually help in propelling the general surgery device market in North America region.

General Surgery Device Market Key Players:

Some of the key market players operating in the general surgery device market include Medtronic, GE Healthcare, Olympus Corporation, Johnson & Johnson, US Medical Innovations, LLC., Virtual Incision, Peters Surgical, CONMED Surgical, Stryker, Abbott, Siemens Healthineers, BD, Boston Scientific Corporation, Baxter International Inc., Philips N.V., CONMED Corporation, Terumo Corporation, 3M, Zimmer Biomet, B. Braun Melsungen, and others.

Recent Developmental Activities In The General Surgery Device Market:

• In May 2024, US Medical Innovations, LLC (USMI) received FDA 510k Clearance for the Canady Helios Cold Plasma™ (CHCP) Ablation System. This system is intended for the ablation of soft tissue during surgical procedures and comprises the Canady Helios Cold Plasma XL-1000 CP Smart Electrosurgical Generator, Canady Helios Cold Plasma Ablators, Foot Pedal, and Trolley Cart.
• In June 2023, LiquiFix Hernia Mesh Fixation device was granted FDA approval. These devices are utilized during surgical interventions to address groin (inguinal) and upper thigh (femoral) hernias.
• In September 2022 Olympus Corporation launched the THUNDERBEAT™ Open Fine Jaw Type X surgical energy devices, catering to open surgery scenarios necessitating delicate and precise tissue dissection, such as thyroidectomy or radical neck dissection.
• In September 2022, Olympus Corporation unveiled the launch of VISERA ELITE III, its latest surgical visualization platform catering to the requirements of healthcare professionals (HCPs) performing endoscopic procedures across various medical disciplines.

Key Takeaways From The General Surgery Device Market Report Study

• Market size analysis for current general surgery device size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the general surgery device market.
• Various opportunities available for the other competitors in the general surgery device market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current general surgery device market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for general surgery device market growth in the coming future?

Target Audience Who Can Be Benefited From This General Surgery Device Market Report Study

• General Surgery Device product providers
• Research organizations and consulting companies
• General surgery devices -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in general surgery device
• Various end-users who want to know more about the general surgery device market and the latest technological developments in the general surgery device market.

Frequently Asked Questions For The General Surgery Device Market:

1. What are general surgery devices?

A general surgery devices encompass a broad range of instruments, equipment, and implants utilized across various surgical procedures. These devices include surgical instruments like electrosurgical devices, endoscopic instruments, and others.

2. What is the market for general surgery devices?

The global general surgery device market is estimated to grow at a CAGR of 5.89% during the forecast period from 2024 to 2030.

3. What are the drivers for the global general surgery device market?

The demand for general surgery devices is primarily being boosted by the growing prevalence of chronic diseases such as cardiovascular diseases, oncological disorders, and others. Several chronic diseases may require surgical intervention for management or treatment thereby boosting the market of general surgery devices. Furthermore, the general surgery device market is anticipated to grow on account of a large number of technological advancements such as the integration of AI assistance in surgery-related devices and an increase in the number of product approvals across the globe. These are the major drivers that are responsible for contributing to the positive growth of the general surgery device market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the global general surgery device market?

Some of the key market players operating in the General Surgery Device are Medtronic, GE Healthcare, Olympus Corporation, Johnson & Johnson, US Medical Innovations, LLC., Virtual Incision, Peters Surgical, CONMED Surgical, Stryker, Abbott, Siemens Healthineers, BD, Boston Scientific Corporation, Baxter International Inc., Philips N.V., CONMED Corporation, Terumo Corporation, 3M, Zimmer Biomet, B. Braun Melsungen, and others.

5. Which region has the highest share in the global general surgery device market?

North America is expected to account for the highest proportion of the general surgery device market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from chronic disease such as cardiovascular and oncological disorders. Additionally, the increase in product approvals and product launches with advanced technology is anticipated to boost the market of general surgical devices in North America.


This product will be delivered within 2 business days.